Total Clarity Wealth Management Inc. Lowers Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Total Clarity Wealth Management Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,867 shares of the healthcare conglomerate’s stock after selling 361 shares during the quarter. Total Clarity Wealth Management Inc.’s holdings in UnitedHealth Group were worth $951,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Swedbank AB acquired a new position in UnitedHealth Group during the first quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Baillie Gifford & Co. grew its position in shares of UnitedHealth Group by 1,125.4% in the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado raised its position in shares of UnitedHealth Group by 3,464.9% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after purchasing an additional 802,160 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. UBS Group boosted their price target on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, September 9th. Argus increased their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Royal Bank of Canada upped their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $594.32 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a 50-day simple moving average of $569.08 and a 200 day simple moving average of $517.70. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a market cap of $548.81 billion, a PE ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $6.14 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 51.34%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.